Brief: PharmaSGP Acquires OTC Brand Portfolio from Gsk

PharmaSGP Holding SE

15/06/2021 17:05

June 15 (Reuters) - PharmaSGP Holding SE  PSGG.DE  SAYS:
    * PHARMASGP GROUP ACQUIRES OTC BRAND PORTFOLIO (BALDRIPARAN,
FORMIGRAN, SPALT  AND KAMOL) FROM GSK
    * AGREED PURCHASE PRICE IS AROUND EUR 80 MLN
    * EXPECTS TRANSACTION TO BE COMPLETED BY END OF AUGUST 2021
    * ACQUISITION IS FINANCED THROUGH A SHAREHOLDER LOAN GRANTED
TO
PHARMASGP HOLDING SE BY FUTRUE GMBH

Source text for Eikon:  ID:nEQbzP7SCa 
Further company coverage:  PSGG.DE 

 ((Frankfurt.newsroom@thomsonreuters.com; +49 7565 1272;))